Mini device implanted during surgery could reveal pancreatic Cancer's drug weaknesses

This early-phase study tests a small device placed into pancreatic tumors during surgery to check how different drugs affect the cancer. Ten adults having their pancreas removed will receive the device, which is taken out with the tumor after about 4 hours. The main goal is to ensure the device is safe and does not cause extra complications. Researchers will also study the tissue around the device to see if the drugs worked, and compare results to lab-grown tumor models.